Even though 2021 presented continuing pandemic challenges for people and organisations worldwide, 2021 was an excellent year for ARMI. Our excellent publication record continued, with several publications in top journals representing high-impact advancements in their fields. As in 2020, a top priority for 2021 was assisting our students to continue their research and learning. Again, the Student Program Committee and the group leaders put in outstanding work steering our student population to help achieve their goals.
ARMI continues to deliver on our Strategic Plan 2020–2025, particularly in developing industry connections and clinical collaborations to improve commercialisation opportunities in bringing innovative stem cell and regenerative medicine technologies to the world.